Behavioral telehealth loses momentum without a regulatory boost

By Salon.com
| January 16, 2023

Restrictions on telehealth prescriptions for controlled substances were waived during the pandemic—but may not last.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...